ACE2 and steatosis: The angiotensin-converting enzyme 2 (ACE2) receptors is a key cell entrance for SARS-CoV-2, which directly contaminates hepatocytes and leads to moderate microvascular steatosis and mild hepatic lobular and portal activity [130,131,132].